AWK vs ZBIO · P/E 22, rev $4.65B vs rev $5.0M
American Water Works (AWK) versus Zenas BioPharma, Inc. Common Stock (ZBIO) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Zenas BioPharma, Inc. Common Stock (ZBIO) is a biotechnology company listed on US.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Latest reported ZBIO revenue for 2024-12-31 was $5.0M. Net income was -$157.0M. Revenue was down 90.0% from 2023-12-31 to 2024-12-31. ZBIO currently screens at market cap $798.0M.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. ZBIO currently screens at market cap $798.0M.
Not investment advice. Open the AWK and ZBIO stock pages for the full models.
Not investment advice.